Anti-PTPRF/ BNAH2/ LAR monoclonal antibody

Anti-PTPRF/ BNAH2/ LAR antibody for FACS & in-vivo assay

Target products collectionGo to PTPRF/PTPRF products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1430-Ab-1/ GM-Tg-hg-MP1430-Ab-2Anti-Human PTPRF monoclonal antibodyHuman
GM-Tg-rg-MP1430-Ab-1/ GM-Tg-rg-MP1430-Ab-2Anti-Rat PTPRF monoclonal antibodyRat
GM-Tg-mg-MP1430-Ab-1/ GM-Tg-mg-MP1430-Ab-2Anti-Mouse PTPRF monoclonal antibodyMouse
GM-Tg-cynog-MP1430-Ab-1/ GM-Tg-cynog-MP1430-Ab-2Anti-Cynomolgus/ Rhesus macaque PTPRF monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1430-Ab-1/ GM-Tg-felg-MP1430-Ab-2Anti-Feline PTPRF monoclonal antibodyFeline
GM-Tg-cang-MP1430-Ab-1/ GM-Tg-cang-MP1430-Ab-2Anti-Canine PTPRF monoclonal antibodyCanine
GM-Tg-bovg-MP1430-Ab-1/ GM-Tg-bovg-MP1430-Ab-2Anti-Bovine PTPRF monoclonal antibodyBovine
GM-Tg-equg-MP1430-Ab-1/ GM-Tg-equg-MP1430-Ab-2Anti-Equine PTPRF monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1430-Ab-1/ GM-Tg-hg-MP1430-Ab-2; GM-Tg-rg-MP1430-Ab-1/ GM-Tg-rg-MP1430-Ab-2;
GM-Tg-mg-MP1430-Ab-1/ GM-Tg-mg-MP1430-Ab-2; GM-Tg-cynog-MP1430-Ab-1/ GM-Tg-cynog-MP1430-Ab-2;
GM-Tg-felg-MP1430-Ab-1/ GM-Tg-felg-MP1430-Ab-2; GM-Tg-cang-MP1430-Ab-1/ GM-Tg-cang-MP1430-Ab-2;
GM-Tg-bovg-MP1430-Ab-1/ GM-Tg-bovg-MP1430-Ab-2; GM-Tg-equg-MP1430-Ab-1/ GM-Tg-equg-MP1430-Ab-2
Products NameAnti-PTPRF monoclonal antibody
Formatmab
Target NamePTPRF
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-PTPRF benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species PTPRF/ BNAH2/ LAR VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1430
    Target NamePTPRF
    Gene ID5792,19268,360406,701160,475389,101081238,512072,100053205
    Gene Symbol and SynonymsBNAH2,LAR,LARFN5C,LARS,PTPRF,RPTP-LAR
    Uniprot AccessionP10586,Q64604,A7MBJ4
    Uniprot Entry NamePTPRF_HUMAN,PTPRF_RAT,PTPRF_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseProstate Cancer
    Gene EnsemblENSG00000142949
    Target ClassificationN/A

    The target: PTPRF, gene name: PTPRF, also named as BNAH2, LAR. The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP possesses an extracellular region, a single transmembrane region, and two tandem intracytoplasmic catalytic domains, and thus represents a receptor-type PTP. The extracellular region contains three Ig-like domains, and nine non-Ig like domains similar to that of neural-cell adhesion molecule. This PTP was shown to function in the regulation of epithelial cell-cell contacts at adherents junctions, as well as in the control of beta-catenin signaling. An increased expression level of this protein was found in the insulin-responsive tissue of obese, insulin-resistant individuals, and may contribute to the pathogenesis of insulin resistance. Two alternatively spliced transcript variants of this gene, which encode distinct proteins, have been reported. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.